Future studies should not only investigate the efficacy of ICIs in treating NSCLC among people living with HIV but also assess their potential effects on HIV replication and CD4+ T cell counts to better evaluate the safety of this treatment in this special population. Here, CD4 is linked to non-small cell lung carcinoma.